$TJX

Benjamin Peter sold $1.8M of TJX

Benjamin Peter (SEVP, Group President) sold 10,926 shares of TJX COMPANIES INC /DE/ (TJX) at $165.00 ($1.80M total) on 2026-06-10.

Original reporting
SEC EDGAR · Benjamin Peter
Published Jun 11, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TJX
Neutral
medium confidence
Mentioned
$TJX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

Provides a new datapoint on insider behavior (open-market sale) but does not introduce new company fundamentals, guidance, or regulatory/legal events.

02

Market read

Traders may monitor insider activity as a sentiment input, but this filing alone is unlikely to drive a sustained repricing.

03

What to watch

Insider sales can be driven by diversification, tax, or personal liquidity needs; without context on prior sales/buybacks, directional inference is weak.

Relevance 6/10Novelty 8/10Timing: Filed June 11 after sale on June 10

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for TJX.

Company-level read

Ticker impact

$TJXNeutralMedium confidence
Context

TJX insider Benjamin Peter (SEVP, Group President) sold 10,926 shares for ~$1.80M via an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited near-term impact; treat as a small sentiment/positioning datapoint rather than a fundamental catalyst.

Evidence & confidence

Form 4 provides a fresh, company-specific fact (sale details), but insider sales are often non-informational and the filing does not include new operational/regulatory developments.

Market effects

Minimal; this is an issuer-specific insider transaction with no stated sector-wide signal.

None indicated.

None indicated.

Counterpoint

Absence of a disclosed 10b5-1 plan could be interpreted by some traders as less “scheduled,” potentially increasing short-term skepticism.

Key entities

  • TJX COMPANIES INC /DE/

    Subject of the SEC Form 4 insider sale by a senior executive.

  • Benjamin Peter

    SEVP, Group President who sold 10,926 shares on June 10.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TJXHighAI 8/10

TJX Raises Fiscal 2027 Outlook as Q2 Results Show Broad-Based Growth

TJX raised its fiscal 2027 profit and earnings outlook after Q2 results exceeded expectations. Adjusted earnings rose 11% to $1.22 per share, and net sales increased 5% to $15.18 billion. Management also increased its long-term store target. Marmaxx, the largest division, showed the weakest growth at 1%, while other divisions performed better.

$TJXMedAI 8/10

Should Investors Buy TJX as Growth Improves but Valuation Stays Rich?

TJX reported strong Q2 results with rising sales and raised its fiscal 2027 earnings guidance to $5.15-$5.20 per share. The company plans to expand its store count to 7,500 and accelerate growth. However, its valuation remains high, with a forward P/S ratio of 2.06, above industry and historical averages. TJX's cash flow and shareholder returns are robust, but execution and cost pressures remain risks.

$TJXHighAI 8/10

TJX Falls 17.4% in the Past Month as Strong Results Meet Key Risks

TJX Companies Inc. (TJX) shares fell 17.4% in the past month despite beating Q2 earnings estimates and raising its full-year outlook. Q2 sales rose 5% to $15.18B, but Marmaxx's 1% comparable sales growth missed expectations. Management cited merchandise mix issues. TJX faces cost pressures from wages, fuel, and currency fluctuations, with Q3 gross margin expected to decline. The stock's valuation remains high, trading at a premium to its sub-industry and historical median.

$TJXMed

Tjx stock hits 52-week low at 125.5 USD

TJX Companies' stock hit a 52-week low of $125.49, down 26% from its high. Despite a 1-year decline of 9.66% and YTD losses of 17%, InvestingPro suggests it may be undervalued. Q2 fiscal 2027 results beat estimates, with $15.2B revenue and $1.22 EPS. Analysts have mixed views, with Jefferies downgrading to Hold, Bernstein maintaining Outperform, and UBS raising its target to $198.